Purine deoxyribonucleotide biosynthetic process

pathway activity — cross-omics
GO:0009153Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Purine deoxyribonucleotide biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are LILRB1, TRBV29-1, and GFI1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Purine deoxyribonucleotide biosynthetic process activity versus LILRB1 in LUAD (Pearson r = 0.27).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADLILRB1 →+0.387+0.120.002<.00134
GBMTRBV29-1 →+0.398+0.166.001.00634
UCECGFI1 →+0.487+0.097.001.00234
LSCCGMPS →+0.652+0.122.003.00834
LSCCHPS3 →+0.507+0.131<.001.00234
LSCCMAPKAP1 →+0.418+0.162.003<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009153 vs LILRB1 — LUAD

Per-sample scatter of Purine deoxyribonucleotide biosynthetic process activity vs LILRB1 in LUAD.

Explore this scatter interactively →

Exploration